Tejaswi Kompala
@tkompala
Followers
449
Following
1K
Media
36
Statuses
294
Clinical Strategy @Teladoc | Endocrinologist via @UCSF | Interests in diabetes, obesity | population health & prevention | behavior change | tweets my own
Salt Lake City, UT
Joined June 2017
🚨 BREAKING: Zepbound (#Tirzepatide) becomes the first-ever FDA-approved drug for Obstructive Sleep Apnea (OSA)! 🌟 https://t.co/FksorF3aqe
17
238
879
Sigh. I'm all for improving our food environment, but we can't go back on all the progress that has been made...
RFK Jr’s nomination is the repudiation of a century of unprecedented and miraculous progress in public health. We take it for granted because we don’t recognize how far we’ve come. I recently wrote in @TheAtlantic about what we risk losing. Gift link 👇 https://t.co/rVXqEzE2qT
0
0
0
Bright spot for me on today's #WorldDiabetesDay2024 was discussing diabetes and wellbeing w colleagues at @TeladocHealth
0
0
2
Interesting modeling study abt deaths averted with hypothetical increase in GLP1/GIP coverage + uptake - with the key point being: It's not just about weight loss. There's real cardiometabolic health risk that can be improved w incretin therapy. https://t.co/XNSeM1mOHH
pnas.org
Obesity is a major public health crisis in the United States (US) affecting 42% of the population, exacerbating a spectrum of other diseases and co...
0
0
2
If MAHA cares about “making Americans healthy” I expect to see: Expansion of Medicare & Medicaid Vaccine requirements for schools Affordable healthcare for ALL Implementing modern agriculture tools for food crops Addressing lies about conventionally-grown foods 1/
115
96
665
Just asked @ZekeEmanuel about what we should be doing next for America’s health to have the greatest impact. His answer made me jump out of my chair. Invest in our children. The earlier, the better. Their nutrition, their education, the right early inventions. We can afford it
19
19
107
standing room only at @RamiBailony re real world long term AOM (1st and 2nd gen) vs intensive behav. Interesting findings: short term AOM use <48 weeks not impactful. ‘focus on the relationships’ - AOMs a tool to help people successfully make behav changes #OW2024 @ObesityWeek
0
2
5
Today is the last day for us to #DoSomething to get @KamalaHarris elected! What a remarkable few months this has been — in record time, she’s built an extraordinary campaign, set forth a clear policy agenda, and proven again and again that she will be working not for herself, but
5K
4K
26K
love Dr Kaplans characterization of obesity care currently as treatment focused — rather than patient focused — arguing that we need to cont working towards comprehensive obesity treatment @ObesityWeek #OW2024
0
2
8
Headed to @ObesityWeek next week? Get your ballots in now! #OW2024
0
0
0
#WeightLoss (14% vs 3% placebo + diet/exercise) with #Wegovy improved knee arthritis, STEP-9 published! @nejm article https://t.co/RRmcFTpiYk
nejm.org
Weight reduction has been shown to alleviate symptoms of osteoarthritis of the knee, including pain. The effect of glucagon-like peptide-1 receptor agonists on outcomes in knee osteoarthritis among...
3
14
47
5 additional areas to add to what we know from pharma trials for real world QOL impact:
0
0
0
We all talk about weight loss + physical health benefits of GLP/GIPs, but so important to broaden the aperture: how is quality of life impacted when on GLP1s for obesity? Here https://t.co/iwUhgWuylp colleagues and I propose further research needed to better understand QOL 👇
dom-pubs.onlinelibrary.wiley.com
Click on the article title to read more.
1
0
1
After a strong start, competition for @novonordisk @EliLillyandCo is coming in the #weightloss space, with widespread innovation to bring options for more people @amgen @Roche @AltimmuneInc @StructureTx @Viking_VKTX @pfizer @Boehringer
https://t.co/XAD2qoRPvX
@TheEconomist
10
100
300
this is what scares me about the obesity and diabetes epidemics --- YOUNG people are impacted, which unfortunately means they grow into adults who will spend more years of their lives with complication, illness.
jamanetwork.com
This Viewpoint discusses the prevalence of youth-onset diabetes and the associated rates of diabetic retinopathy and addresses the need for surveillance of patients with youth-onset diabetes.
0
0
0
so important for expanded equitable access to cardiometabolic care
statnews.com
Most state Medicaid programs don’t cover weight loss drugs for obesity, but that could soon change.
0
1
3
The benefits of incretin-memetic drugs (IMD) are clear 💉 The benefits of physical activity and nutrition therapy are clear 🏋️♂️🥦 This is not an either/or debate. A comprehensive weight management program should include both. Figure Source: https://t.co/qJlywLzVHC
3
10
26
*Breaking* Top-line results positive of the highly anticipated #SOUL trial, the first powered CVOT of an oral #GLP1RA 14% reduction in MACE with oral semaglutide among 9,650 people with T2D and established CV disease and/or CKD https://t.co/hWeEuEayCZ
2
68
133
Love this reply by Dr Dayspring keeping it real: "speak to your physician and instead of fearing incredibly efficacious and safe statins, fear ASCVD (which statins can safely prevent)"
Regarding last night's tweet by @ErinMichos about what Peter Libby (world's top ASCVD thought leader) thinks about desirable LDL-C. Let's never forget this statement of his posted below - Cholesterol and LDL Deniers - it would be admirable if you would all please admit how
0
0
1
Great reminder on why it matters to KNOW and TRUST who you are working with for your healthcare. GLP1s arent just candy to be handed out - people deserve to be getting actual comprehensive obesity CARE, like what we do at @TeladocHealth or my own practice at the @UUtah
Hundreds of telehealth sites now offer compounded GLP-1s. But who's actually writing those prescriptions? I dug in for @statnews and found a surprisingly small number of medical groups behind the scenes of dozens of sites cashing in on the GLP-1 boom:
0
0
4